Influence of impaired renal function on the outcomes of patients with acute ischaemic stroke treated with intravenous tenecteplase and alteplase: a post hoc analysis of the TRACE-2 trial

Influence of impaired renal function on the outcomes of patients with acute ischaemic stroke treated with intravenous tenecteplase and alteplase: a post hoc analysis of the TRACE-2 trial

Objective Limited evidence is available regarding the risk-benefit ratio of thrombolytic therapy in patients with stroke and renal impairment complications, particularly for the drug tenecteplase. Therefore, we examined the association of impaired renal function with the safety and efficacy of intra...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yongjun Wang, Yilong Wang, Xia Meng, Yuesong Pan, Yu Wu, Yilun Zhou, Wanliang Du, Shuya Li, Mengxing Wang
Format:	Article
Language:	English
Published:	BMJ Publishing Group
Series:	Stroke and Vascular Neurology
Online Access:	https://svn.bmj.com/content/early/2025/03/18/svn-2024-003726.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tenecteplase Versus Alteplase in Acute Ischemic Stroke in Chinese Patients: Protocol for the ORIGINAL Study
by: Xia Meng, et al.
Published: (2024-07-01)

Alteplase vs. Tenecteplase: An In-depth Analysis of Their Relative Effectiveness in Treating Acute Ischemic Stroke
by: Muhammad Junaid Azhar, et al.
Published: (2024-10-01)

Tenecteplase compared to alteplase in real-world outcome: A Swedish Stroke Register study
by: Mikael Skärlund, et al.
Published: (2024-10-01)

CLINICAL RESULTS OF THROMBOLYTIC THERAPY WITH ALTEPLASE AND TENECTEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION
by: L. A. Bondarenko, et al.
Published: (2015-12-01)

Abstract 069: Alteplase Or Tenecteplase Prior To Endovascular Therapy – Does It Matter?
by: Sheetal Hegde, et al.
Published: (2023-11-01)

Tenecteplase versus alteplase in patients with acute ischemic stroke: an updated systematic review and meta-analysis
by: Abdelmonam M. Hagag, et al.
Published: (2025-08-01)

Tenecteplase vs alteplase as bridging thrombectomy in ischemic stroke patients: a systematic review and meta analysis
by: Salim Harris, et al.
Published: (2025-08-01)

Emergency Department Workflow Times of Intravenous Thrombolysis with Tenecteplase versus Alteplase in Acute Ischemic Stroke: A Prospective Cohort Study before and during the COVID-19 Pandemic
by: Matias Guzman, et al.
Published: (2025-02-01)

A Systematic Review of the Efficacy and Safety of Tenecteplase Versus Alteplase in Acute Ischemic Stroke: A Time to Pass the Torch
by: Miguel Rodriguez, et al.
Published: (2024-07-01)

Abstract 040: Hemorrhagic Conversion Patterns After Transition of Stroke Thrombolysis from Alteplase to Tenecteplase; Real‐World Experience
by: Mohamad Ezzeldin, et al.
Published: (2023-11-01)

Tenecteplase thrombolytic therapy for acute ischaemic stroke in China: a real-world, multicentre, retrospective, controlled study
by: Peng Li, et al.

Renal function and efficacy of dual antiplatelet vs. alteplase in minor stroke: a post hoc analysis of ARAMIS study
by: Xiao-Yi He, et al.
Published: (2025-04-01)

Alteplase- and Tenecteplase-Related Errors and Risk Mitigation Strategies in the Treatment of Acute Ischemic Stroke: A Study of Event Reports From 52 Hospitals
by: Myungsun Ro, et al.
Published: (2024-06-01)

Secondary prevention medication persistence and prognosis of acute ischaemic stroke or transient ischaemic attack
by: Lei Zhang, et al.
Published: (2021-09-01)

Comparative Efficacy and Safety of Different Tenecteplase Doses With Alteplase in Acute Ischemic Stroke: A Systematic Review With Pairwise and Network Meta‐Analysis to Determine the Optimal Dose
by: Muhammad Hassan Waseem, et al.
Published: (2025-08-01)

Clinical Outcomes after Intravenous Alteplase in Elderly Patients with Acute Ischaemic Stroke: A Retrospective Analysis of Patients Treated at a Tertiary Neurology Centre in England from 2013 to 2018
by: Xuya Huang, et al.
Published: (2021-01-01)

Switch to tenecteplase for intravenous thrombolysis in stroke patients: experience from a German high-volume stroke center
by: Alexander Sekita, et al.
Published: (2025-05-01)

Association between hospital volume, processes of care and outcomes after acute ischaemic stroke: a prospective observational study
by: Yongjun Wang, et al.
Published: (2022-06-01)

Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA stratified by age and renal function: CHANCE-2 trial substudy
by: Yu Wu, et al.
Published: (2025-12-01)

Efficacy and Safety of Intravenous Tenecteplase Before Endovascular Thrombectomy for Acute Ischemic Stroke: The Multicenter, Randomized, BRIDGE‐TNK Trial Protocol
by: Zhongming Qiu, et al.
Published: (2024-11-01)

Efficacy, Influencing Factors, and Safety of Alteplase Intravenous Thrombolysis in Patients with Acute Ischemic Stroke Combined with Atrial Fibrillation
by: Yongyin Zhang, et al.
Published: (2022-01-01)

Tenecteplase for Minor Stroke: Does Sex Matter?
by: Beom Joon Kim
Published: (2025-05-01)

A comparative study of thrombolysis in cases of prosthetic mitral valve replacement dysfunction between intravenous alteplase and intravenous urokinase
by: Maulik Sharma, et al.
Published: (2025-01-01)

Efficacy of argatroban plus alteplase according to time from onset to thrombolysis in acute ischemic stroke: a prespecified post-hoc analysis of the ARAIS trial
by: Yu Cui, et al.
Published: (2025-06-01)

Effect of intravenous alteplase before endovascular therapy for atherothrombotic stroke-related large vessel occlusion: subanalysis of the RESCUE AT-LVO registry
by: Takanori Sano, et al.

Rationale and Study Design to Assess the Efficacy and Safety of Minocycline in Patients with Moderate to Severe Acute Ischaemic Stroke (EMPHASIS)
by: Liping Liu, et al.

Administration of Cilostazol Prior to Intravenous Alteplase for Acute Branch Atheromatous Disease: A Report of Three Cases
by: Eijirou Tanaka, et al.
Published: (2025-01-01)

Tenecteplase in acute ischemic stroke: a new era in thrombolysis
by: Gisele Sampaio Silva, et al.
Published: (2025-05-01)

Abstract 073: Thrombectomy Alone Versus Bridging Intravenous Alteplase in A US Population: Regression Discontinuity Analysis
by: Ngoc Mai Le, et al.
Published: (2023-11-01)

Intra-arterial alteplase for acute ischaemic stroke after mechanical thrombectomy (PEARL): rationale and design of a multicentre, prospective, open-label, blinded-endpoint, randomised controlled trial
by: Jie Li, et al.
Published: (2024-11-01)

Successful use of intra venous tenecteplase for acute ischemic stroke in pregnancy
by: Balamurugan Namasivayam, et al.
Published: (2024-09-01)

Oxidised low-density lipoprotein and adverse outcome in patients with acute mild ischaemic stroke or high-risk TIA: a secondary analysis of the INSPIRES randomised clinical trial
by: Yilong Wang, et al.

Argatroban plus alteplase in posterior versus anterior circulation stroke
by: Yu Cui, et al.
Published: (2025-02-01)

A new nomogram for predicting 90-day outcomes of intravenous thrombolysis in patients with acute ischaemic stroke
by: Yingjie Zhao, et al.
Published: (2025-02-01)

Relationship Between Neutrophil Count and 90‐Day Outcomes and Effect of Dual Antiplatelet Therapy in Patients With Acute Ischemic Stroke or Transient Ischemic Attack: A Post Hoc Analysis of the INSPIRES Trial
by: Yicong Wang, et al.
Published: (2025-07-01)

Chinese stroke association guidelines on reperfusion therapy for acute ischaemic stroke 2024
by: Liping Liu, et al.

Intrapleural Tenecteplase for Complicated Parapneumonic Pleural Effusion
by: Husain Kadhem, et al.
Published: (2021-01-01)

COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE
by: V. V. Omel'yanovskiy, et al.
Published: (2016-01-01)

Prognostic Impact of 1‐Year Changes in Creatinine‐ and Cystatin C‐Based Estimated Glomerular Filtration Rate After Stroke on 5‐Year Outcomes: Insights From the Third China National Stroke Registry
by: Yin Zhang, et al.
Published: (2025-01-01)

Dual antiplatelet versus alteplase in anterior and posterior circulation minor stroke
by: Yu Cui, et al.